Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 24% ± 6% | |
brain | 13 studies | 33% ± 12% | |
peripheral blood | 8 studies | 18% ± 3% | |
eye | 7 studies | 29% ± 10% | |
kidney | 6 studies | 25% ± 5% | |
intestine | 5 studies | 27% ± 11% | |
heart | 5 studies | 22% ± 4% | |
placenta | 4 studies | 29% ± 13% | |
uterus | 4 studies | 36% ± 7% | |
lymph node | 4 studies | 23% ± 7% | |
breast | 4 studies | 29% ± 11% | |
liver | 4 studies | 36% ± 15% | |
prostate | 4 studies | 20% ± 2% | |
adipose | 4 studies | 28% ± 9% | |
pancreas | 3 studies | 44% ± 20% | |
esophagus | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 9352.50 | 2628 / 2642 | 100% | 82.35 | 702 / 705 |
thymus | 100% | 18064.93 | 653 / 653 | 99% | 96.39 | 596 / 605 |
esophagus | 100% | 13664.80 | 1438 / 1445 | 98% | 51.85 | 180 / 183 |
liver | 100% | 10614.95 | 226 / 226 | 98% | 57.26 | 396 / 406 |
prostate | 100% | 14264.98 | 244 / 245 | 98% | 60.94 | 491 / 502 |
adrenal gland | 100% | 18252.83 | 258 / 258 | 97% | 50.56 | 223 / 230 |
breast | 100% | 21682.14 | 459 / 459 | 97% | 206.95 | 1081 / 1118 |
kidney | 100% | 10309.22 | 89 / 89 | 96% | 91.78 | 861 / 901 |
lung | 100% | 22376.26 | 578 / 578 | 95% | 54.34 | 1103 / 1155 |
uterus | 100% | 15099.32 | 170 / 170 | 85% | 31.44 | 392 / 459 |
skin | 97% | 17431.70 | 1760 / 1809 | 85% | 53.42 | 401 / 472 |
ovary | 100% | 14384.36 | 180 / 180 | 79% | 23.11 | 339 / 430 |
pancreas | 84% | 4781.67 | 276 / 328 | 94% | 51.88 | 167 / 178 |
stomach | 99% | 9284.66 | 354 / 359 | 79% | 35.92 | 225 / 286 |
bladder | 100% | 15553.90 | 21 / 21 | 66% | 23.51 | 331 / 504 |
intestine | 100% | 12589.31 | 965 / 966 | 65% | 22.94 | 344 / 527 |
blood vessel | 100% | 18668.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 14573.61 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 25397.03 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 9233.34 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 8474.33 | 825 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 37.66 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 70% | 30.18 | 56 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 22.47 | 17 / 29 |
peripheral blood | 35% | 1836.13 | 329 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0034097 | Biological process | response to cytokine |
GO_0038165 | Biological process | oncostatin-M-mediated signaling pathway |
GO_0048711 | Biological process | positive regulation of astrocyte differentiation |
GO_0038154 | Biological process | interleukin-11-mediated signaling pathway |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0070120 | Biological process | ciliary neurotrophic factor-mediated signaling pathway |
GO_0070102 | Biological process | interleukin-6-mediated signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0060576 | Biological process | intestinal epithelial cell development |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0002821 | Biological process | positive regulation of adaptive immune response |
GO_0002675 | Biological process | positive regulation of acute inflammatory response |
GO_1901731 | Biological process | positive regulation of platelet aggregation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0048861 | Biological process | leukemia inhibitory factor signaling pathway |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0070106 | Biological process | interleukin-27-mediated signaling pathway |
GO_0005896 | Cellular component | interleukin-6 receptor complex |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005900 | Cellular component | oncostatin-M receptor complex |
GO_0070110 | Cellular component | ciliary neurotrophic factor receptor complex |
GO_0019970 | Molecular function | interleukin-11 binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0004924 | Molecular function | oncostatin-M receptor activity |
GO_0004897 | Molecular function | ciliary neurotrophic factor receptor activity |
GO_0004915 | Molecular function | interleukin-6 receptor activity |
GO_0004923 | Molecular function | leukemia inhibitory factor receptor activity |
GO_0019955 | Molecular function | cytokine binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0030296 | Molecular function | protein tyrosine kinase activator activity |
GO_0045509 | Molecular function | interleukin-27 receptor activity |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0004921 | Molecular function | interleukin-11 receptor activity |
GO_0005138 | Molecular function | interleukin-6 receptor binding |
GO_0004896 | Molecular function | cytokine receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0005127 | Molecular function | ciliary neurotrophic factor receptor binding |
GO_0019981 | Molecular function | interleukin-6 binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IL6ST |
Protein name | IL6ST nirs variant 6 (Interleukin 6 cytokine family signal transducer) IL6ST nirs variant 2 IL6ST nirs variant 3 (Interleukin 6 cytokine family signal transducer) Interleukin 6 cytokine family signal transducer IL6ST isoform 4 IL6ST nirs variant 5 Interleukin 6 signal transducer (Gp130, oncostatin M receptor) IL6ST nirs variant 1 (Interleukin 6 cytokine family signal transducer) IL6ST isoform 3 (Interleukin 6 cytokine family signal transducer) Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130) |
Synonyms | |
Description | FUNCTION: Signal-transducing molecule . The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Binding of IL6 to IL6R induces IL6ST homodimerization and formation of a high-affinity receptor complex, which activates the intracellular JAK-MAPK and JAK-STAT3 signaling pathways . That causes phosphorylation of IL6ST tyrosine residues which in turn activates STAT3 . In parallel, the IL6 signaling pathway induces the expression of two cytokine receptor signaling inhibitors, SOCS1 and SOCS3, which inhibit JAK and terminate the activity of the IL6 signaling pathway as a negative feedback loop (By similarity). Also activates the yes-associated protein 1 (YAP) and NOTCH pathways to control inflammation-induced epithelial regeneration, independently of STAT3 (By similarity). Acts as a receptor for the neuroprotective peptide humanin as part of a complex with IL27RA/WSX1 and CNTFR . Mediates signals which regulate immune response, hematopoiesis, pain control and bone metabolism (By similarity). Has a role in embryonic development (By similarity). Essential for survival of motor and sensory neurons and for differentiation of astrocytes (By similarity). Required for expression of TRPA1 in nociceptive neurons (By similarity). Required for the maintenance of PTH1R expression in the osteoblast lineage and for the stimulation of PTH-induced osteoblast differentiation (By similarity). Required for normal trabecular bone mass and cortical bone composition (By similarity). .; FUNCTION: [Isoform 2]: Binds to the soluble IL6:sIL6R complex (hyper-IL6), thereby blocking IL6 trans-signaling. Inhibits sIL6R-dependent acute phase response . Also blocks IL11 cluster signaling through IL11R . . |
Accessions | ENST00000577363.2 Q5FC07 ENST00000698643.1 Q5FC02 Q17RA0 A0A8V8TM11 P40189 ENST00000698638.1 A0A8V8TNI8 ENST00000381298.7 [P40189-1] D6RH03 A0A0A0N0L2 ENST00000381286.7 ENST00000698648.1 Q5FC03 A0A8V8TMJ4 ENST00000503773.6 ENST00000698647.1 A0A8V8TNI4 Q5FC06 ENST00000522633.2 [P40189-2] ENST00000698641.1 A0A0A0N0L5 ENST00000502326.7 [P40189-1] ENST00000698644.1 ENST00000651614.1 ENST00000698639.1 ENST00000381293.6 ENST00000698640.1 ENST00000698642.1 ENST00000381294.8 [P40189-3] ENST00000698645.1 [P40189-1] Q5FC05 ENST00000698646.1 A0A8V8TNU5 A0A8V8TMJ9 A0A494BZU0 |